Coughing is a common adverse reaction of thyroid surgery,which could result in postoperative bleeding.Postoperative bleeding is a serious and potentially life-threatening complication,which could result in acute upper airway obstruction due to neck hematoma and increase the need for re-operation.The purpose of this study is to investigate whether dexmedetomidine can reduce the incidence of postoperative coughing and contribute to postoperative recovery in patients undergoing tyroid surgery with general anesthesia.
Thyroid surgery is a common clinical surgery,the incidence of postoperative coughing is up to 32.4%.Coughing response could result in postoperative bleeding,even cause respiratory tract obstruction,affect patients' postoperative recovery .Dexmedetomidine,an α2 adrenergic agonist,has hypnotic,analgesic, anxiolytic,antisympathetic effects,which could facilitate the sedation of patients while maintaining their consciousness and keep respiration and circulation stable .For these benefits,dexmedetomidine was widely used for general anesthesia.However,whether dexmedetomidine can reduce the incidence of postoperative coughing is unclear.Therefore,the investigators conduct this randomized controlled double-blind trial,to investigate the effects of dexmedetomidine on coughing and postoperative recovery quality in patients undergoing tyroid surgery with general anesthesia.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
118
Dexmeditomidine 0.2 ug/kg·h will be administered to participants by intravenous infusion at the beginning of the surgery,and continued till end of surgery.
Isovolumetric normal saline will be administered to participants by intravenous infusion at the beginning of the surgery,and continued till end of surgery.
The First Affliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
the incidence of coughing
coughing will be observed
Time frame: within 48 hours postoperatively
coughing on a four-point scale
coughing on a four-point scale will be measured within 48 hours postoperatively
Time frame: within 48 hours postoperatively
the eyes opening time
the eyes opening time will be observed
Time frame: within 48 hours postoperatively
the time of extubation
the time of extubation will be recorded
Time frame: within 48 hours postoperatively
visual analogue scale (VAS)
visual analogue scale will be measured at 30 minutes after extubation
Time frame: at 30 minutes after extubation
sedation-agitation scale(SAS)
sedation-agitation scale will be measured at 30 minutes after extubation
Time frame: at 30 minutes after extubation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.